Abstract
Aim: This study aimed to investigate the effects of relaxin (RLX) on hypertensive disorders of pregnancy (HDP) and fetal growth restriction (FGR) using a nitric oxide synthase (NOS) inhibitor-induced HDP murine model.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have